Thursday, November 19, 2026

Subscribe

EconomyEdition TunisiaTunisia

Could BCG save Tunisia’s cattle herds from bovine TB and decline?

Tunisia plans to test the BCG vaccine against bovine tuberculosis as its livestock numbers fall and animal-health pressures mount. The trial will assess its effectiveness before any possible nationwide rollout.

Diplomatic meeting in Tunis on animal health, with documents, interpretation headsets and discreet flags.

A herd under pressure, a sector to protect

When a farm loses animals, it also loses milk, meat, income and time. In Tunisia, this vulnerability takes on particular significance because the livestock sector remains closely tied to food security, rural incomes and the stability of a sector already tested by successive droughts. The Tunisian government therefore wants to act before the disease costs farmers and slaughterhouses even more.

On 20 July 2026, the authorities paved the way for a pilot trial of vaccination against bovine tuberculosis using BCG, the vaccine familiar from human medicine. The aim is not to replace existing tools, but to test additional protection under Tunisian conditions against a disease that affects livestock and can also be transmitted to humans. Veterinary services point out that efforts to tackle it already rely on surveillance, biosecurity, controls on animal movements and herd testing.

A decision forming part of a broader strategy

The initiative comes as Tunis has put rebuilding livestock numbers at the centre of its roadmap. In early July, the authorities presented a 2026–2030 plan to revive livestock farming after several years of structural decline. The programme aims to restore cattle and sheep herds, increase fodder resources, digitise animal monitoring and strengthen animal health.

The economic context explains the urgency. Livestock farming carries considerable weight in Tunisian agriculture. Official documents and information reported by the press show that it accounts for a significant share of rural activity, while agriculture more broadly still represents a notable proportion of employment and national output. Public policy is therefore addressing more than veterinary health. It also affects prices, supplies to urban markets and the survival of small and medium-sized farms.

Tunisia’s livestock numbers have fallen sharply. Data from the National Institute of Statistics show a decline in cattle, sheep and goats between 2016 and 2022. According to the series published by the INS, the total herd fell from around 8.37 million head to 5.94 million, a contraction of about 29%. This decline is adding to pressure on meat and milk supplies, as well as limiting farmers’ ability to rebuild their animal capital after losses.

What vaccination changes, and what it does not replace

Bovine tuberculosis is an infectious disease caused by Mycobacterium bovis. The World Organisation for Animal Health says it mainly affects cattle, but can also affect other domestic animals and, in some cases, humans. Transmission occurs notably through contact with infected animals or through consumption of contaminated milk and products. Signs in animals include weight loss and pneumonia, and the disease can ultimately lead to death.

In this context, BCG may seem like an attractive solution. The WOAH nevertheless stresses that it is not a simple tool to roll out widely among animals. Vaccination can disrupt surveillance because it makes some screening test results harder to interpret. The organisation’s guidelines therefore emphasise that BCG can complement other strategies, but does not replace testing or sanitary control of outbreaks.

This is precisely the sensitive point in the Tunisian case. If the pilot trial confirms a reduction in infections or losses, vaccination could become a useful tool for herds already weakened by drought and rising feed costs. However, if the results are modest or screening tests become harder to interpret, the operational benefits will be limited. The decision will therefore depend not only on the vaccine’s biological efficacy, but also on its compatibility with existing veterinary practices.

The public-health dimension remains significant. Tunisian professional sources have cited around 1,500 cases of human tuberculosis a year in the country, a large proportion of them said to be of animal origin. While this figure should be treated with caution and remains attributed to a professional source, it serves as a reminder that animal disease can place a burden on health services, farmers, veterinarians and slaughterhouse workers.

A national and regional issue

Tunisia is making progress within a broader framework of animal health and the spread of disease across the Maghreb. The issue extends beyond the country’s borders, as livestock movements, climate pressures and trade in animal products create shared risks. In North Africa, health coordination remains essential, even though Tunisia does not belong to an economic subregional organisation as integrated as ECOWAS or SADC. Here, the most relevant reference points are Maghreb cooperation and the continental standards of the AU and WOAH.

The case also says something broader about African agricultural policies. Governments are now seeking solutions that cost less, are better suited to the climate and are more widely accepted by farmers. Tunisia is trying to combine disease prevention, herd rebuilding and secure food supplies. If the BCG trial succeeds, it could provide a model for other countries facing vulnerable herds, limited veterinary resources or the persistent spread of zoonoses. If it fails, it will instead underline that a lasting response depends first and foremost on testing, biosecurity, fodder and the control of animal movements.

In the short term, the issue will be decided over the coming months, as the pilot is potentially launched and health and economic results are published. That will show whether Tunisia can turn a laboratory test into a public-policy tool for its livestock sector.

Automatic translation. Original French version

The quiz

Edition TunisiaTunisia in 5 questions

5 questions